MIRM (STOCKS)
Mirum Pharmaceuticals, Inc. Common Stock
$102.010000
+2.130000 (+2.13%)
Prev close: $99.880000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher Peetz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,272.78M
- Employees
- 355
- P/E (TTM)
- -118.37
- P/B (TTM)
- 17.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.05 | $-0.17 | +0.2180 | +129.76% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.33 | +0.2130 | +63.96% |
|
Mar 2025 (Q1)
|
$-0.30 | $-0.34 | +0.0359 | +10.69% |
|
Dec 2024 (Q4)
|
$-0.49 | $-0.25 | -0.2443 | -99.43% |
Financial Statements
| Revenues | $471.79M |
| Benefits Costs and Expenses | $512.62M |
| Costs And Expenses | $512.62M |
| Operating Expenses | $513.59M |
| Selling, General, and Administrative Expenses | $239.73M |
| Other Operating Expenses | $273.85M |
| Operating Income/Loss | -$41.79M |
| Income/Loss From Continuing Operations After Tax | -$41.42M |
| Income/Loss From Continuing Operations Before Tax | -$40.83M |
| Income Tax Expense/Benefit | $593.00K |
| Net Income/Loss | -$41.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$41.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$41.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.84 |
| Diluted Earnings Per Share | -$0.84 |
| Basic Average Shares | 49,963,909 |
| Diluted Average Shares | 49,963,909 |
| Assets | $785.12M |
| Current Assets | $530.58M |
| Inventory | $24.02M |
| Other Current Assets | $506.55M |
| Noncurrent Assets | $254.54M |
| Fixed Assets | $1.28M |
| Intangible Assets | $231.90M |
| Other Non-current Assets | $21.37M |
| Liabilities | $493.07M |
| Current Liabilities | $160.36M |
| Accounts Payable | $12.17M |
| Wages | $36.98M |
| Other Current Liabilities | $111.21M |
| Noncurrent Liabilities | $332.71M |
| Equity | $292.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $292.05M |
| Liabilities And Equity | $785.12M |
| Net Cash Flow From Operating Activities | $44.69M |
| Net Cash Flow From Operating Activities, Continuing | $44.69M |
| Net Cash Flow From Investing Activities | -$24.32M |
| Net Cash Flow From Investing Activities, Continuing | -$24.32M |
| Net Cash Flow From Financing Activities | $36.48M |
| Net Cash Flow From Financing Activities, Continuing | $36.48M |
| Net Cash Flow | $56.86M |
| Net Cash Flow, Continuing | $56.86M |
| Comprehensive Income/Loss | -$42.31M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.31M |
| Other Comprehensive Income/Loss | -$883.00K |